SCHEMBL4915684

SCHEMBL4915684

O=C(NO)c1ccccc1C(=O)Nc1ccccc1S

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.61
MDM4 O15151 4/20 0.61
MDM2 Q00987 2/20 0.54
GAA P10253 3/20 0.49
LMNA P02545 3/20 0.49
HTT P42858 2/20 0.49
NPC1 O15118 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MPO P05164 1/20 0.48
HIF1A Q16665 1/20 0.48
HPGD P15428 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
HDAC8 Q9BY41 2/20 0.44
MMP3 P08254 1/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923542 0.92 TP53 (0.56) TP53MDM4MDM2GAALMNA
SCHEMBL4923978 0.88 TP53 (0.51) TP53MDM4MDM2GAALMNA
SCHEMBL7154697 0.86 MDM4 (0.66) TP53MDM4MDM2NPC1KDM4E
SCHEMBL14890169 0.81 CYP1A2 (0.74) TP53MDM4MDM2LMNAKDM4E
SCHEMBL4930820 0.80 NPC1 (0.76) TP53GAALMNAHTTNPC1
SCHEMBL5245919 0.79 HDAC1 (0.61) TP53GAALMNAHTTNPC1
SCHEMBL6320366 0.78 TP53 (0.56) TP53MDM4MDM2GAALMNA
SCHEMBL1331243 0.78 GAA (0.73) GAALMNASMN1; SMN2KDM4EMPO
SCHEMBL333488 0.76 MDM4 (1.00) TP53MDM4MDM2NPC1HPGD
SCHEMBL6002243 0.74 MDM4 (0.96) TP53MDM4MDM2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 TP53 4175/4885MDM4 4834/4885MDM2 3894/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 TP53 4132/4885MDM4 4828/4885MDM2 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.